Bellicum Pharmaceuticals Inc. (BLCM) Rose 9.75% or 0.82 To Price $9.23 On Tuesday


Bellicum Pharmaceuticals Inc. (BLCM) rose 9.75% or 0.82 to $9.23. It is approximately 541000 shares traded, which is 143.45% compare to the average total volume 377137. The market cap of BLCM is $306.95 million. The 52 week price range is from $7.41 to $15.55. Price of BLCM have changed -3.67% during last week. It have changed -15.14% over last month, -28.79% over last 3 months, -28.12% over last 6 months and -39.45% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BLCM is 9.50. It is 2.93% above current price. The 200-day Moving Averages for BLCM is 11.07. It is 19.93% above current price. The 52-week High is 15.55. It is 68.47% from the current price. The 52-week Low is 7.41. It is -19.72% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of BLCM is 12.63 on 2017-12-15. Short % to float is 14.06%. There are some statistics of BLCM. It is has market cap $306.95 million. The share outstanding is 33.26 million. The average volume is 377137. The percent of top 15 Institution holding is 53.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BLCM is -83.07%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BLCM is -61.83%.


Tags:

Share this post